Leerink Swann Downgrades Pharmasset (VRUS) to Market Perform; A Befitting End to a Remarkable Biotech Story
Go back to Leerink Swann Downgrades Pharmasset (VRUS) to Market Perform; A Befitting End to a Remarkable Biotech Story| Gilead Sciences (NASDAQ: GILD) | Delayed: 146.12 +2.68 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.44 | 52 Week High | $108.63 | |||
| Open | $144.52 | 52 Week Low | $71.39 | |||
| Day High | $147.91 | P/E | 80.73 | |||
| Day Low | $143.50 | EPS | $1.81 | |||
| Volume | 5,384,368 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 270.24 +2.87 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $267.37 | 52 Week High | $126.07 | |||
| Open | $267.83 | 52 Week Low | $94.28 | |||
| Day High | $272.66 | P/E | 56.18 | |||
| Day Low | $267.00 | EPS | $4.81 | |||
| Volume | 6,186,395 | |||||
| Pharmasset, Inc. (AMEX: VRUS) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $137.81 | |||
| Open | $67.86 | 52 Week Low | $46.49 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.25 | |||
| Volume | 34,954 | |||||
